Ledger.Open graph →
SEC Form D · filed January 21, 2026

Cantai Therapeutics, Inc

Offering
$3.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

James P. Scopa · South San Francisco, CAExecMatthew Armendariz · Calabasas, CAExec · DirectorGetta B. Vemuri · Philadelphia, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗